← Eichor
Study identifier: NCT07169799 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Impact of Cryotherapy Spray (Tru-Freeze) for the Eradication of Gastric Antral Vascular Ectasia (ICE-GAVE)

Condition: Gastric Antral Vascular Ectasia  ·  Sponsor: Mayo Clinic

PhaseNA
Planned participants50
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The purpose of this study is to evaluate the impact of cryotherapy spray treatment for eradication of gastric antral vascular ectasia by measuring the change in hemoglobin levels and transfusion requirements in the first 6 months of cryotherapy treatment compared to the previous 6 months

This description comes directly from the study's public registry record.

Talk to the study team

Stephanie McNew  ·  904-953-0580  ·  mcnew.stephanie@mayo.edu

Kristen Lozano  ·  lozano.kristen@mayo.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Mayo Clinic in FloridaJacksonville, Florida, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07169799